The initial stage of development of AIDS Research at CWRU was characterized by extensive growth along areas of institutional strength (international aspects of AIDS, mycobacterial research), commitment of resources to develop molecular virology and essential core services such as the BL-3 facility, coordination of clinical care and research in a single unit, and training individuals with a variety of backgrounds to participate in AIDS Research. The proposed CFAR will allow a second phase of development, a crystallization of efforts through a central administrative structure and development of state-of-the-art cores that will allow an expanded research agenda. At this particular stage in evolution of AIDs research at CWRU, the Developmental Core is particularly important from two standpoints. The first is that effective use of this funding will allow coordinated development of research activities to promote optimal utilization of the CFAR core facilities. The second, and a distinctive feature of the CWRU CFAR, will be directed application of the developmental finding to enhance collaboration between basic and clinical scientists. The following is the rationale for utilization of development funds. Year 01 will be an important year for development of core facilities and enhancement of interdisciplinary research among investigators at CWRU. Two pilot projects will be supported in year 01 ($40,000 each). In year 02, funds are requested for four pilot projects ($40,000 each). Two pilot projects will be supported in year 03, three in year 04 and four in year 05, all at $40,000 each. Funds committed by the Internal Advisory Committee for evolving research opportunities will be obtained from the budget set aside for pilot projects. A new investigator will be recruited to start in year 03; salary support ($50,000 per year) and start-up funds ($80,000 year 03, $40,000 per year in years 04 and 05) will be committed for three years.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI036219-01
Application #
3747631
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Llewellyn, George N; Alvarez-Carbonell, David; Chateau, Morgan et al. (2018) HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. J Neurovirol 24:192-203
Longenecker, Chris T; Sullivan, Claire E; Morrison, Justin et al. (2018) The effects of HIV and smoking on aortic and splenic inflammation. AIDS 32:89-94
Tomas, Myreen E; Mana, Thriveen S C; Wilson, Brigid M et al. (2018) Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice. Antimicrob Agents Chemother 62:
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Sahmoudi, Karima; Abbassi, Hassan; Bouklata, Nada et al. (2018) Immune activation and regulatory T cells in Mycobacterium tuberculosis infected lymph nodes. BMC Immunol 19:33
Webel, Allison R; Moore, Shirley M; Longenecker, Chris T et al. (2018) Randomized Controlled Trial of the SystemCHANGE Intervention on Behaviors Related to Cardiovascular Risk in HIV+ Adults. J Acquir Immune Defic Syndr 78:23-33
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Eckard, Allison Ross; O'Riordan, Mary Ann; Rosebush, Julia C et al. (2018) Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther 23:315-324
Webel, Allison R; Perazzo, Joseph; Longenecker, Christopher T et al. (2018) The Influence of Exercise on Cardiovascular Health in Sedentary Adults With Human Immunodeficiency Virus. J Cardiovasc Nurs 33:239-247
Yan, Junpeng; Shun, Ming-Chieh; Hao, Caili et al. (2018) HIV-1 Vpr Reprograms CLR4DCAF1 E3 Ubiquitin Ligase to Antagonize Exonuclease 1-Mediated Restriction of HIV-1 Infection. MBio 9:

Showing the most recent 10 out of 539 publications